SARS-CoV-2 as a trigger of IgA vasculitis: a clinical case and literature review
Rheumatology International · 2024
DOI: 10.1007/s00296-024-05712-3 ↗Kurz gefasst
Fallbericht in der Zeitschrift Rheumatology International, 2024. Verfasst von Akerke Auanassova und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology and Biochemistry, South Kazakhstan Medical Academy, Shymkent, Kazakhstan. Hauptthemen laut MEDLINE: COVID-19, IgA Vasculitis, Methylprednisolone, SARS-CoV-2. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 53 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biology and Biochemistry, South Kazakhstan Medical Academy, Shymkent, Kazakhstan.
- Department of Physical Medicine and Rehabilitation, University of Health Sciences, Adana Health Practice and Research Center, Adana, Türkiye. bfk2701@hotmail.com.
ORCID-Profile: Akerke Auanassova, Marlen Yessirkepov, Burhan Fatih Kocyigit
Zitieren
APA
Auanassova, A., Yessirkepov, M., & Kocyigit, B. F. (2024). SARS-CoV-2 as a trigger of IgA vasculitis: a clinical case and literature review. Rheumatology International. https://doi.org/10.1007/s00296-024-05712-3
Vancouver
Auanassova A, Yessirkepov M, Kocyigit BF. SARS-CoV-2 as a trigger of IgA vasculitis: a clinical case and literature review. Rheumatology International. 2024. doi:10.1007/s00296-024-05712-3
BibTeX
@article{Auanassova2024,
author = {Auanassova, Akerke and Yessirkepov, Marlen and Kocyigit, Burhan Fatih},
title = {SARS-CoV-2 as a trigger of IgA vasculitis: a clinical case and literature review},
journal = {Rheumatology International},
year = {2024},
doi = {10.1007/s00296-024-05712-3}
}
EUVIMED